Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07169799 · ClinicalTrials.gov registry record · NA

Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)

A NA study of Gastric Antral Vascular Ectasia, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07169799 is a NA study of Gastric Antral Vascular Ectasia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07169799, a NA study of Gastric Antral Vascular Ectasia, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the impact of cryotherapy spray treatment for eradication of gastric antral vascular ectasia by measuring the change in hemoglobin levels and transfusion requirements in the first 6 months of cryotherapy treatment compared to the previous 6 months

Interventions

  • OTHER trūFreeze® Spray Cryotherapy System (STERIS Endoscopy)

Study Locations (1)

Florida

  • Mayo Clinic in Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-09-22
Est. Completion 2028-12-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT07169799

The ClinicalTrials.gov registry entry for NCT07169799 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastric Antral Vascular Ectasia appearing as the primary indexed condition, and to 1 intervention - of which trūFreeze® Spray Cryotherapy System (STERIS Endoscopy) is the first listed.

NCT07169799 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07169799 about?

NCT07169799 is a clinical study titled "Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)". The purpose of this study is to evaluate the impact of cryotherapy spray treatment for eradication of gastric antral vascular ectasia by measuring the change in hemoglobin levels and transfusion requirements in the first 6 months of cryotherapy treatment compared to the previous 6 months

What is the current status of trial NCT07169799?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-09-22. Estimated completion is 2028-12-31.

What conditions does trial NCT07169799 study?

This clinical trial studies the following conditions: Gastric Antral Vascular Ectasia.

What interventions are being tested in trial NCT07169799?

The interventions under investigation include: trūFreeze® Spray Cryotherapy System (STERIS Endoscopy) (OTHER).

Who is sponsoring clinical trial NCT07169799?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07169799 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastric Antral Vascular Ectasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.